» Articles » PMID: 11112161

Proceedings of the ATS Workshop on Refractory Asthma: Current Understanding, Recommendations, and Unanswered Questions. American Thoracic Society

Overview
Specialty Critical Care
Date 2000 Dec 9
PMID 11112161
Citations 319
Affiliations
Soon will be listed here.
Citing Articles

Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?.

Arismendi E, Ribo P, Garcia A, Torrego A, Bobolea I, Casas-Saucedo R J Clin Med. 2024; 13(22).

PMID: 39597790 PMC: 11594371. DOI: 10.3390/jcm13226646.


Mitochondrial DNA copy number variation in asthma risk, severity, and exacerbations.

Xu W, Hong Y, Hu B, Comhair S, Janocha A, Zein J J Allergy Clin Immunol. 2024; .

PMID: 39237012 PMC: 11875079. DOI: 10.1016/j.jaci.2024.08.022.


Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 Continents.

Park S, Fowler S, Shaw D, Adcock I, Sousa A, Djukanovic R Allergy Asthma Immunol Res. 2024; 16(4):338-352.

PMID: 39155735 PMC: 11331196. DOI: 10.4168/aair.2024.16.4.338.


Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial.

Chen R, Wei L, Dai Y, Wang Z, Yang D, Jin M ERJ Open Res. 2024; 10(3).

PMID: 38770009 PMC: 11103715. DOI: 10.1183/23120541.00750-2023.


Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies.

Liu T, Woodruff P, Zhou X Eur Respir J. 2024; 64(2).

PMID: 38697650 PMC: 11325267. DOI: 10.1183/13993003.00826-2023.